{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:24Z","timestamp":1794473364228,"version":"4.9.1"},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,15]]},"DOI":"10.2169\/internalmedicine.7292-21","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T22:08:54Z","timestamp":1636927734000},"page":"3517-3523","source":"Crossref","is-referenced-by-count":3,"title":["P2Y12 Inhibitors Exacerbate Low-dose Aspirin-induced Small Bowel Injury in Dual Antiplatelet Therapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Yukiko","family":"Handa","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Osawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Murao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Handa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Umegaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol 110: 1265-1287; quiz 1288, 2015.","DOI":"10.1038\/ajg.2015.246"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carey EJ, Leighton JA, Heigh RI, et al. A single-center experience of 260 consecutive patients undergoing capsule endoscopy for obscure gastrointestinal bleeding. Am J Gastroenterol 102: 89-95, 2007.","DOI":"10.1111\/j.1572-0241.2006.00941.x"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 133: 1694-1696, 2007.","DOI":"10.1053\/j.gastro.2007.06.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 43: 581-588, 2008.","DOI":"10.1007\/s00535-008-2206-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 53: 216-220, 2001.","DOI":"10.1067\/mge.2001.112181"},{"key":"6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/35013140","volume":"405","author":"G Iddan","year":"2000","unstructured":"6. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 405: 417, 2000.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka S, Mitsui K, Yamada Y, et al. Diagnostic yield of double-balloon endoscopy in patients with obscure GI bleeding. Gastrointest Endosc 68: 683-691, 2008.","DOI":"10.1016\/j.gie.2008.03.1062"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsumoto T, Kudo T, Esaki M, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 43: 490-496, 2008.","DOI":"10.1080\/00365520701794121"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 3: 55-59, 2005.","DOI":"10.1016\/S1542-3565(04)00603-2"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 128: 1172-1178, 2005.","DOI":"10.1053\/j.gastro.2005.03.020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Watanabe T, Sugimori S, Kameda N, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 6: 1279-1282, 2008.","DOI":"10.1016\/j.cgh.2008.06.021"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Smecuol E, Pinto Sanchez MI, Suarez A, et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 7: 524-529, 2009.","DOI":"10.1016\/j.cgh.2008.12.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Endo H, Hosono K, Inamori M, et al. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 44: 544-549, 2009.","DOI":"10.1007\/s00535-009-0040-z"},{"key":"14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000204465","volume":"79","author":"H Endo","year":"2009","unstructured":"14. Endo H, Hosono K, Inamori M, et al. Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 79: 44-51, 2009.","journal-title":"Digestion","ISSN":"https:\/\/id.crossref.org\/issn\/0012-2823","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hara A, Ota K, Takeuchi T, et al. Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study. J Clin Biochem Nutr 63: 224-229, 2018.","DOI":"10.3164\/jcbn.18-16"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rollini F, Franchi F, Angiolillo DJ. Switching P2Y12-receptor inhibitors in patients with coronary artery disease. Nat Rev Cardiol 13: 11-27, 2016.","DOI":"10.1038\/nrcardio.2015.113"},{"key":"17","unstructured":"17. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 152: 1243-1275, 2016."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Valgimigli M, Bueno H, Byrne RA, et al. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS]. Kardiol Pol 75: 1217-1299, 2017 (in Polish).","DOI":"10.5603\/KP.2017.0224"},{"key":"19","unstructured":"19. Dai X, Makaryus AN, Makaryus JN, Jauhar R. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Rev Cardiovasc Med 10: 14-24, 2009."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tan VP, Yan BP, Kiernan TJ, Ajani AE. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med 10: 36-44, 2009.","DOI":"10.1016\/j.carrev.2008.11.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shiotani A, Honda K, Murao T, et al. Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury. Scand J Gastroenterol 46: 281-286, 2011.","DOI":"10.3109\/00365521.2010.533381"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shiotani A, Haruma K, Nishi R, et al. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 45: 292-298, 2010.","DOI":"10.3109\/00365520903453182"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Iwamoto J, Mizokami Y, Saito Y, et al. Small bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding. World J Gastroenterol 20: 13133-13138, 2014.","DOI":"10.3748\/wjg.v20.i36.13133"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 98: 6470-6475, 2001.","DOI":"10.1073\/pnas.111150798"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Achen MG, Stacker SA. The vascular endothelial growth factor family; proteins which guide the development of the vasculature. Int J Exp Pathol 79: 255-265, 1998.","DOI":"10.1046\/j.1365-2613.1998.700404.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Szabo S, Vincze A. Growth factors in ulcer healing: lessons from recent studies. J Physiol Paris 94: 77-81, 2000.","DOI":"10.1016\/S0928-4257(00)00146-7"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. O&apos;Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.","DOI":"10.1016\/S0092-8674(00)81848-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yamaguchi N, Anand-Apte B, Lee M, et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18: 4414-4423, 1999.","DOI":"10.1093\/emboj\/18.16.4414"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 275: H1054-H1061, 1998.","DOI":"10.1152\/ajpheart.1998.275.3.H1054"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hwang DL, Lev-Ran A, Yen CF, Sniecinski I. Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction. Regul Pept 37: 95-100, 1992.","DOI":"10.1016\/0167-0115(92)90658-H"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Linder BL, Chernoff A, Kaplan KL, Goodman DS. Release of platelet-derived growth factor from human platelets by arachidonic acid. Proc Natl Acad Sci U S A 76: 4107-4111, 1979.","DOI":"10.1073\/pnas.76.8.4107"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wartiovaara U, Salven P, Mikkola H, et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80: 171-175, 1998.","DOI":"10.1055\/s-0037-1615158"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Endo H, Higurashi T, Hosono K, et al. Efficacy of <i>Lactobacillus casei<\/i> treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol 46: 894-905, 2011.","DOI":"10.1007\/s00535-011-0410-1"},{"key":"34","unstructured":"34. Nikolsky E, Stone GW, Kirtane AJ, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 54: 1293-1302, 2009."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol 102: 2411-2416, 2007.","DOI":"10.1111\/j.1572-0241.2007.01460.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, Investigators C. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J 157: 369-374, 2009.","DOI":"10.1016\/j.ahj.2008.09.011"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ko DT, Yun L, Wijeysundera HC, et al. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circ Cardiovasc Interv 3: 140-147, 2010.","DOI":"10.1161\/CIRCINTERVENTIONS.109.928721"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358: 527-533, 2001.","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nadatani Y, Watanabe T, Tanigawa T, et al. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Scand J Gastroenterol 48: 320-325, 2013.","DOI":"10.3109\/00365521.2012.758771"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7292-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T03:24:19Z","timestamp":1637378659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7292-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":39,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7292-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"article-number":"7292-21"}}